Endocrine, Metabolic & Antidiabetic Medications

Glyvanza 30 mg Modified Release Tablet

Gliclazide

Division

Human Health

Generic name

Gliclazide

Strength

30 mg

Form

Modified Release Tablet

Pack size

30 tablets

Therapeutic segment

Endocrine, Metabolic & Antidiabetic Medications

Indication

Glyvanza 30 mg is a medicine that reduces blood sugar levels (oral antidiabetic medicine belonging to the sulfonylurea group). Glyvanza 30 mg is used in a certain form of diabetes (type 2 diabetes mellitus) in adults, when diet, exercise and weight loss alone do not have an adequate effect on keeping blood sugar at the correct level.